FIELD: medicine.
SUBSTANCE: purified RNA synthesised in vitro by nonviral transfection is introduced into placental and cord cells. RNA comprises at least one sequence providing cell transition to a pluripotent state.
EFFECT: method allows increasing efficiency of preparing selected somatic pluripotent cells, reducing probability of oncogenesis and other negative consequences of cell reprogramming, and eliminating invasiveness at the stage of preparation of the cell material.
10 dwg, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF PRODUCING INDUCED PLURIPOTENT STEM CELLS FROM FIBROBLASTS OF PATIENTS WITH HUNTINGTON'S DISEASE | 2011 |
|
RU2458983C1 |
| METHOD OF PRODUCTION OF INDUCED PLURIPOTENT STEM CELLS OF PATIENTS WITH DOWN SYNDROME | 2012 |
|
RU2492233C1 |
| METHOD FOR INCREASING RNA EXPRESSION IN CELL | 2018 |
|
RU2784654C2 |
| METHOD FOR PRODUCING HIGH-QUALITY INDUCED PLURIPOTENT STEM CELLS (IPSC) | 2016 |
|
RU2721266C1 |
| OBTAINING PLURIPOTENT CELLS DE NOVO | 2013 |
|
RU2696071C2 |
| METHOD FOR OBTAINING ENDOTHELIOCYTES FROM HUMAN EMBRYONIC STEM CELLS (VERSIONS) | 2008 |
|
RU2359030C1 |
| EVALUATION METHOD OF MORPHOFUNCTIONAL STATE OF INDUCED PLURIPOTENT STEM CELLS OF PARKINSONIAN PATIENTS, WHICH ARE DIFFERENTIATED TO DOPAMINERGIC NEURONS | 2012 |
|
RU2501853C1 |
| METHODS AND PRODUCTS FOR EXPRESSION OF PROTEINS IN CELLS | 2013 |
|
RU2711249C2 |
| STIMULATION OF PATHWAY Wnt IN REPROGRAMMING SOMATIC CELLS | 2008 |
|
RU2492232C2 |
| RECOMBINANT PLASMID pOK-DsRed2, CODING OCT4 AND KLF4 HUMAN PROTEINS AND FLUORESCENT PROTEIN DsRed2, DESIGNED TO PRODUCE INDUCED PLURIPOTENT HUMAN STEM CELLS | 2011 |
|
RU2495125C2 |
